FTC Staff Comment to Department of Labor on Proposed Amendments to Regulations Implementing the Mental Health Parity and Addiction Equity Act
Date
Matter Number
P184503
Docket Number
REG-120727-2
Displaying 1 - 20 of 48
FTC Staff Comment to the FDA Department of Health and Human Services on Its Updated Guidance for Industry on the “Nonproprietary Naming of Biological Products”
Date
Matter Number
V190001
Docket Number
FDA-2013-D-1543
File
Text of the FTC Staff Comment
(52.95 KB)
Federal Trade Commission Comment On the Food and Drug Administration’s Revised Draft Guidance For Industry, Entitled “Citizen Petitions and Petitions For Stay of Action Subject To Section 505(q) of the Federal Food, Drug, and Cosmetic Act.”
Date
Matter Number
P013510
Docket Number
FDA-2009-D-0008
File
FTC Staff Comment Submitted to the Food and Drug Administration, In Response to FDA's Request For Comments on Its Guidance for Industry on the “Nonproprietary Naming of Biological Products; Draft Guidance for Industry; Availability”
Date
Matter Number
P131208
Docket Number
FDA-2013-D-1543 [80 Fed. Reg. 52296 (Aug. 28, 2015)]
FTC staff submitted a comment to the FDA, in response to the FDA’s request for comment on its draft guidance addressing nonproprietary names for biological products. The comment expressed concern that...
File
Text of the FTC Staff Comment
(125.01 KB)
FTC Staff Comment to the Honorable James L. Seward Concerning New York Senate Bill 58 on Pharmacy Benefit Managers (PBMs)
Date
Matter Number
V090006
Related Release
FTC Staff Comment to Hon. Terry Kilgore Concerning Virginia House Bill No. 945 to Regulate the Contractual Relationship Between PBMs, Health Benefit Plans, and Pharmacies
Date
Matter Number
V060018
Related Release
FTC Comment to the Food and Drug Administration Concerning Response to Citizen Petition by IVAX Pharmaceuticals Relating to Generic Drug Application
Date
Matter Number
V050006
Related Release
FTC Staff Comment Before the Food and Drug Administration Concerning Consumer-Directed Promotion
Date
Matter Number
V040016
FTC Staff Comments Before the Food and Drug Administration Concerning Consumer-Directed Promotion
Date
Matter Number
V040002
Displaying 1 - 20 of 48